Layer 1
Mhra

Refine

E.g., 23/03/2019
E.g., 23/03/2019

Refine

Refine

E.g., 23/03/2019
E.g., 23/03/2019

mhra

Following an EU review, the MHRA is updating product information for carbimazole
New evidence of congenital malformations with carbimazole, MHRA warns
There is an increased risk of congenital malformations for women taking the anti-thyroid agent, “especially when administered in the first trimester...
21/02/2019 0
EXCLUSIVE
MHRA: Diversion of diazepam 10mg is down 73% thanks to our investigation
MHRA investigating 25 pharmacies as part of POM diversion crackdown
The investigation into “an extensive network of criminality” diverting POMs to be sold illegally online was first announced by the Medicines and...
13/02/2019 8
There are currently very few FMD-compliant medicine packs for pharmacy staff to scan
Pharmacies warned of false FMD alerts day before law comes into force
The EU’s anti-counterfeit legislation, the Falsified Medicines Directive (FMD) – which requires all pharmacies to be able to scan barcodes on...
08/02/2019 22
EXCLUSIVE
64% of contractors unprepared for FMD, while no-deal doubts confirmed
Of the 53 contractors who responded to the C+D Salary Survey 2018 in October – 88% of whom were based in England – 64% said they were unprepared for...
04/01/2019 12
MHRA: Pharmacies should stop supplying the affected batches “immediately”
Valsartan batches by Teva and Mylan recalled over carcinogen concerns
The Medicines and Healthcare products Regulatory Agency (MHRA) issued the recall this morning (November 30), after it became aware of a contaminant...
30/11/2018 1
Matt Hancock
Hancock: Pharmacists must support May’s Brexit deal to ensure supply
Mr Hancock was responding yesterday (November 27) to a question from Labour MP for Burnley Julie Cooper, who pointed to NHS Confederation warnings...
28/11/2018 18
Bristol Labs manufacturing suspension extended by three months
The Medicines and Healthcare products Regulatory Agency (MHRA) first issued a partial suspension of the manufacturer’s licence in August 2017, after...
27/11/2018 4
The MHRA is keen to improve yellow card reporting in community pharmacy
Why aren’t pharmacists reporting more adverse drug reactions?
For a medicine to be considered safe, its expected benefits should outweigh any associated risks of harmful reactions. All medicines undergo safety...
23/11/2018 0
EXCLUSIVE
31% of respondents to C+D's poll submitted a yellow card report in the past year
Almost half of pharmacists rarely or never report adverse reactions
Almost a third (31%) of 107 community pharmacist respondents to the poll – which C+D ran between August and September 2018 – said they had submitted...
23/11/2018 2
How community pharmacy can give medicines the yellow card
What’s the first thing that comes to your mind when you hear the words ‘yellow card’? Do you think of a football referee giving a player a caution,...
23/11/2018 0

Pages